A. Karniguian

706 total citations
23 papers, 591 citations indexed

About

A. Karniguian is a scholar working on Hematology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, A. Karniguian has authored 23 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 7 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in A. Karniguian's work include Platelet Disorders and Treatments (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Protease and Inhibitor Mechanisms (5 papers). A. Karniguian is often cited by papers focused on Platelet Disorders and Treatments (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Protease and Inhibitor Mechanisms (5 papers). A. Karniguian collaborates with scholars based in France, Germany and Netherlands. A. Karniguian's co-authors include Y Legrand, Ahmed Zahraoui, A Tavitian, Jacques Caen, Jany Vassy, Irina Abécassis, michel schmid, Gérard Zalcman, Birgitta Olofsson and F Fauvel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biochemical Journal.

In The Last Decade

A. Karniguian

23 papers receiving 568 citations

Peers

A. Karniguian

PHYSI

HEMAT

H S Banga United States

Victor Babich United States

Constanze Blume Germany

Ben M. de Koster Netherlands

F. Gauthier France

M. Gorovoy United States

C Helţianu Czechia

J. Krause Germany

Donald W. Lawrence United States

Maarten Vanwildemeersch Sweden

H S Banga United States

A. Karniguian

311 ×1.4

66 ×0.4

PHYSI

186 ×1.3

HEMAT

63 ×0.5

74 ×0.8

Citations per year, relative to A. Karniguian A. Karniguian (= 1×) peers H S Banga

Countries citing papers authored by A. Karniguian

Since Specialization

Citations

This map shows the geographic impact of A. Karniguian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Karniguian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Karniguian more than expected).

Fields of papers citing papers by A. Karniguian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Karniguian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Karniguian. The network helps show where A. Karniguian may publish in the future.

Co-authorship network of co-authors of A. Karniguian

This figure shows the co-authorship network connecting the top 25 collaborators of A. Karniguian. A scholar is included among the top collaborators of A. Karniguian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Karniguian. A. Karniguian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Segal, E., et al.. (2012). cFos Mediates cAMP-Dependent Generation of ROS and Rescue of Maturation Program in Retinoid-Resistant Acute Promyelocytic Leukemia Cell Line NB4-LR1. PLoS ONE. 7(11). e50408–e50408. 3 indexed citations

Azouz, Abdulkader, Josette Hillion, A. Karniguian, et al.. (2010). Epigenetic plasticity of hTERT gene promoter determines retinoid capacity to repress telomerase in maturation-resistant acute promyelocytic leukemia cells. Leukemia. 24(3). 613–622. 24 indexed citations

Abécassis, Irina, Johan Maes, Josette Hillion, et al.. (2007). Re-expression of DNA methylation-silenced CD44 gene in a resistant NB4 cell line: rescue of CD44-dependent cell death by cAMP. Leukemia. 22(3). 511–520. 14 indexed citations

Abécassis, Irina, Birgitta Olofsson, michel schmid, Gérard Zalcman, & A. Karniguian. (2003). RhoA induces MMP-9 expression at CD44 lamellipodial focal complexes and promotes HMEC-1 cell invasion. Experimental Cell Research. 291(2). 363–376. 89 indexed citations

Vassy, Jany, Stéphanie Portet, Michael Beil, et al.. (2001). Effect of weightlessness on cytoskeleton architecture and proliferation of human breast cancer cell line MCF‐7. The FASEB Journal. 15(6). 1104–1106. 21 indexed citations

Vassy, Jany, Stéphanie Portet, Michael Beil, et al.. (2001). The effect of weightlessness on cytoskeleton architecture and proliferation of human breast cancer cell line MCF-7. The FASEB Journal. 15(6). 1104–1106. 102 indexed citations

Ménager, Céline, et al.. (1999). Subcellular Localization of RhoA and Ezrin at Membrane Ruffles of Human Endothelial Cells: Differential Role of Collagen and Fibronectin. Experimental Cell Research. 249(2). 221–230. 47 indexed citations

Karniguian, A., Ahmed Zahraoui, & A Tavitian. (1993). Identification of small GTP-binding rab proteins in human platelets: thrombin-induced phosphorylation of rab3B, rab6, and rab8 proteins.. Proceedings of the National Academy of Sciences. 90(16). 7647–7651. 84 indexed citations

Karniguian, A., et al.. (1990). Human autoantibodies identify a nuclear chromatin-associated antigen (PSL or p55) in human platelets.. PubMed. 51(1). 183–7. 4 indexed citations

10.

Karniguian, A., Françoise Grelac, S Lévy-Toledano, Y Legrand, & Francine Rendu. (1990). Collagen-induced platelet activation mainly involves the protein kinase C pathway. Biochemical Journal. 268(2). 325–331. 28 indexed citations

11.

Fauvel, F, et al.. (1985). Collagen induced platelet aggregation : A comparison between several commercially available collagens. Thrombosis Research. 38(6). 707–711. 5 indexed citations

12.

Karniguian, A., et al.. (1985). Inhibition of Some Activities of Thrombin by a Collagen-Derived Octapeptide. Pathophysiology of Haemostasis and Thrombosis. 15(5). 293–299. 3 indexed citations

13.

Pintigny, D, C. Legrand, A. Karniguian, Y Legrand, & J Caen. (1985). Evidence that a collagen derived octapeptide inhibits fibrinogen binding to platelets stimulated by collagen and not by ADP. Biochemical and Biophysical Research Communications. 128(2). 547–553. 11 indexed citations

14.

Bevers, Edouard M., A. Karniguian, Y Legrand, & R.F.A. Zwaal. (1985). Collagen derived octapeptide inhibits platelet procoagulant activity induced by the combined action of collagen and thrombin. Thrombosis Research. 37(3). 365–370. 3 indexed citations

15.

Legrand, Y, A. Karniguian, F Fauvel, & N Gutman. (1983). The molecular interaction between platelet and vascular wall.. PubMed. 9(2). 263–74. 3 indexed citations

16.

Karniguian, A., et al.. (1983). Effect of a collagen derived octapeptide on different steps of the platelet / collagen interaction. Thrombosis Research. 32(6). 593–604. 22 indexed citations

17.

Karniguian, A., et al.. (1982). A comparison of the inhibitory effects of prostacyclin and carbacyclin on platelet adhesion to collagen. Prostaglandins. 24(6). 827–836. 6 indexed citations

18.

Legrand, Y, A. Karniguian, & F Fauvel. (1981). [The adhesion of blood platelets to collagen: molecular features of collagen (author's transl)].. PubMed. 23(3). 143–8. 1 indexed citations

19.

Legrand, Y, F Fauvel, N Gutman, et al.. (1980). Microfibrils (MF) platelet interaction : Requirement of von Willebrand factor. Thrombosis Research. 19(4-5). 737–739. 19 indexed citations

20.

Legrand, Y, et al.. (1980). Evidence that a collagen-derived nonapeptide is a specific inhibitor of platelet-collagen interaction. Biochemical and Biophysical Research Communications. 96(4). 1579–1585. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact